Joshua Rucker
INBU250
Malaria Vaccine
Background:
Malaria is a disease of the blood that is caused by the female Anopheles mosquito, it is
the only mosquito that transmits malaria, the disease is then transmitted from person to person.
Once the parasite enters the human body, it lodges itself in the liver where it multiplies
approximately 10,000 times (Malariavaccine, 2017). Two weeks after entering the body, the
parasite bursts into the blood stream where it begins infecting red blood cells. Malaria is one of
the world’s deadliest diseases, and more than 200 million people are infected with malaria each
year. This disease is considered one of the top child killers on the planet, it also prevents
children from going to school, families from investing in their future, and communities from
prospering, taking a huge toll on lives, livelihoods, and countries’ progress. If drugs are not
available to the infected, or if the parasites are resistant to them, malaria infection can eventually
lead to anemia, hypoglycemia, cerebral malaria, and in some cases death. Zacapharm is one of
the world’s leading pharmaceutical companies. In 2013 it had revenues of $54.3 billion and net
income of $10.1 billion. Its current business strategy is to maximize revenues from existing